Nitric oxide synthase inhibitors enhance the antinociceptive effects of oxotremorine in mice

Polish Journal of Pharmacology

Volumn 49, Issue 1, 1997, Pages 31-36

  Pavone, Flaminia ^a   Capone, Francesca ^b   Populin, Roberta ^a   Przewłocka, Barbara ^c  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

mice; nitric oxide; nociception; oxotremorine; tail flick

Indexed keywords

MUSCARINIC RECEPTOR; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXOTREMORINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; TAIL FLICK TEST;

ANALGESICS; ANIMALS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; MALE; MICE; MUSCARINIC AGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXOTREMORINE; PAIN MEASUREMENT; TIME FACTORS;

EID: 0030972145     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aanonsen L. M., Lei S., Wilcox G. L.: Excitatory amino acid receptors and nociceptive neurotransmission in the rat spinal cord. Pain, 1990, 41, 309-321.
2. Babbedge R. C., Hart S. L., Moore P.K.: Antinociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J. Pharm. Pharmacol., 1993, 45, 77-79.
3. Beckman J. S., Beckman T.: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Nat. Acad. Sci. USA, 1993, 87, 1620-1624.
4. Cahusac P. M. B., Evans R. H., Hill R. G., Rodriguez R. E., Smith D. A. S.: The behavioral effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology, 1984, 23, 719-724.
5. Culcasi M., Lafon-Cazal M., Pietri S., Bockaert J.: Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J. Biol. Chem., 1994, 269, 12589-12593.
6. Duarte I. D. G., Ferreira S. H.: The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol., 1992, 217, 225-227.
7. Duarte I. D. G., Lorenzetti B. B., Ferreira S. H.: Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol., 1990, 186, 289-293.
8. Garthwaite J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 1991, 14, 60-67.
9. Haley J. E., Dickenson A. H., Schachter M.: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology, 1992, 31, 251-258.
10. G-nitro arginine, a selective inhibitor of nitric oxide biosynthesis, exhibits antinociceptive activity in the mouse. Eur. J. Pharmacol., 1990, 83, 1440-1441.
11. Hughes S. R., Williams T. J., Brain S. D.: Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur. J. Pharmacol., 1990, 91, 481-484.
12. Ialenti A., Ianaro A., Moncada S., Di Rosa M.: Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol., 1992, 177-182.
13. Iwamoto E. T., Marion L.: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther., 1993, 266, 329-338.
14. Iwamoto E. T., Marion L.: Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J. Pharmacol. Exp. Ther., 1994, 269, 699-708.
15. Iwamoto E. T., Marion L.: Pharmacological evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J. Pharmacol. Exp. Ther., 1994, 271, 601-608.
16. Kawabata A., Nishimura Y., Takagi H.: L-Leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia. Brit. J. Pharmacol., 1992, 07, 1096-1101.
17. Kawabata A., Umeda N., Takagi H.: L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Brit. J. Pharmacol., 1993, 109, 73-79.
18. Kitto K. F., Haley J. E, Wilcox G. L.: Involvement of nitric oxide in spinally-mediated hyperalgesia in the mouse. Neurosci. Lett., 1992, 148, 1-5.
19. Malmberg A. B., Yaksh T. L.: Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain, 1993, 54, 291-300.
20. Meller S. T., Dykstra C., Gebhart G. F.: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol., 1992, 214, 93-96.
21. Meller S. T., Lewis S. J., Bates J. N., Brody M. J., Gebhart G.F.: Is there a role for an endothelium-derived relaxing factor in nociception? Brain Res., 1990, 531, 342-345.
22. Meller S. T., Pechman P. S., Gebhart G. F., Maves T. J.: Nitric oxide mediates the thermal hyperalgesia produced in a model of neurophatic pain in the rat. Neuroscience, 1992, 50, 7-10.
23. Metyš J., Wagner N., Metyšová J., Herz A.: Studies on the central antinociceptive action of cholinomimetic agents. Int. J. Neuropharmacol., 1969, 8, 413-425.
24. Moncada S., Palmer R. M. J., Higgs E. A.: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
25. Moore P. K., Babbedge R. C., Wallace P., Gaffen Z. A., Hart S.L.: 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Brit. J. Pharmacol., 1993, 108, 296-297.
26. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Brit. J. Pharmacol., 1991, 102, 198-202.
27. Pavone F., Battaglia M., Sansone M.: Attenuation of cholinergic analgesia by nifedipine. Brain Res., 1993, 623, 308-310.
28. Przewłocki R., Machelska H., Przewłocka B.: Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci., 1993, 53, 1-5.
29. Snyder S. H., Bredt D. S.: Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci., 1991, 12, 125-128.
30. Takagi H., Harima A., Shimizu H.: A novel clinical treatment of persistent pain with L-arginine. Eur. J. Pharmacol., 1990, 183, 1443.
31. Tseng L. F., Xu J.Y., Pieper G.M.: Increase of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse. Eur. J. Pharmacol., 1992, 212, 301-303.
32. Xu J. Y., Tseng L. F.: Role of nitric oxide/cyclic GMP in i.c.v. administered, β-endorphin and (+)-cis-dioxolane-induced antinociception in the mouse. Eur. J. Pharmacol., 1994, 262, 223-231.
33. Yaksh T. L., Dirksen R., Harty G. J.: Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol., 1985, 117, 81-88.
34. Zhuo M,. Gebhart G. F.: Tonic cholinergic inhibition of spinal mechanical transmission. Pain, 1991, 46, 211-222.
35. Zhuo M., Meller S. T., Gebhart G. F.: Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain, 1993, 54, 71-78.